This page shows the latest Annexa news and features for those working in and with pharma, biotech and healthcare.
Portola Pharmaceuticals and Bristol-Myers Squibb (BMS) has reported phase III data on its Factor Xa inhibitor antidote Annexa (andexanet alfa), showing it can effectively reverse the anticoagulant effects of
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...